Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fowler

Showing results (771-780 of 957) with videos related to

Pageof 96
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2023
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyRobert F Ozols, Brian N Bundy, Benjamin E Greer, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Not Forgotten: Patient Experiences with Genetic Variant ReclassificationsPankhuri Gupta, Min Seon Park, Eric Y Kao, et al.
Gynecologic Oncology|March 6, 2012
Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer stagingFloor J Backes, Lorna A Brudie, M Ryan Farrell, et al.
Gynecologic Oncology|July 29, 2015
Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer CenterMargaret I Liang, Adam C ElNaggar, Silpa Nekkanti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2016
Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective CohortFloor J Backes, Adam C ElNaggar, Michael Ryan Farrell, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2013
Activity-enhancing mutations in an E3 ubiquitin ligase identified by high-throughput mutagenesisLea M Starita, Jonathan N Pruneda, Russell S Lo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2013
Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?Floor J Backes, Debra L Richardson, Georgia A McCann, et al.
Gynecologic Oncology|February 6, 2019
Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancerMegan L Hutchcraft, Blair Smith, Eric M McLaughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group studyRobert F Ozols, Brian N Bundy, Benjamin E Greer, et al.
Plos One|April 19, 2018
Chloroplast variation is incongruent with classification of the Australian bloodwood eucalypts (genus Corymbia, family Myrtaceae)Tanja M Schuster, Sabrina D Setaro, Josquin F G Tibbits, et al.
Pageof 96

Showing results (771-780 of 957) with videos related to

Sort By:
Pageof 96
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2023
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyRobert F Ozols, Brian N Bundy, Benjamin E Greer, et al.
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Not Forgotten: Patient Experiences with Genetic Variant ReclassificationsPankhuri Gupta, Min Seon Park, Eric Y Kao, et al.
Gynecologic Oncology|March 6, 2012
Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer stagingFloor J Backes, Lorna A Brudie, M Ryan Farrell, et al.
Gynecologic Oncology|July 29, 2015
Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer CenterMargaret I Liang, Adam C ElNaggar, Silpa Nekkanti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2016
Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective CohortFloor J Backes, Adam C ElNaggar, Michael Ryan Farrell, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2013
Activity-enhancing mutations in an E3 ubiquitin ligase identified by high-throughput mutagenesisLea M Starita, Jonathan N Pruneda, Russell S Lo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2013
Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?Floor J Backes, Debra L Richardson, Georgia A McCann, et al.
Gynecologic Oncology|February 6, 2019
Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancerMegan L Hutchcraft, Blair Smith, Eric M McLaughlin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2003
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group studyRobert F Ozols, Brian N Bundy, Benjamin E Greer, et al.
Plos One|April 19, 2018
Chloroplast variation is incongruent with classification of the Australian bloodwood eucalypts (genus Corymbia, family Myrtaceae)Tanja M Schuster, Sabrina D Setaro, Josquin F G Tibbits, et al.
Pageof 96